Three-dimensional Structure of Mammalian Casein Kinase I: Molecular Basis for Phosphate Recognition
Overview
Molecular Biology
Authors
Affiliations
The three-dimensional structure for the catalytic region of the mammalian protein kinase, casein kinase I delta (CKI delta), has been solved by X-ray crystallography to a resolution of 2.3 A. A truncation mutant of CKI delta lacking the C-terminal autoinhibitory region was expressed in Escherichia coli, purified, and crystallized. The structure was solved by molecular replacement using the crystal structure of the catalytic domain of a CKI homolog from Schizosaccharomyces pombe, Cki1. A tungstate derivative confirmed the initial molecular replacement solution and identified an anion binding site which may contribute to the unique substrate specificity of CKI. Like other protein kinases, the catalytic domain of CKI is composed of two lobes with a cleft between them for binding ATP. Comparison of the mammalian and yeast CKI structures suggests that a rotation of the N-terminal domain occurs upon ATP binding. This domain motion is similar, but not identical, to that observed in cAMP-dependent protein kinase upon binding ATP. Although Cki1 has many similarities to CKI delta over the catalytic domain, these two forms of CKI likely perform different functions in vivo. Relating the primary sequences of other CKI enzymes to the three-dimensional architecture of CKI delta reveals a catalytic face that is especially conserved among the subset of CKI family members associated with the regulation of DNA repair.
Markovian State Models uncover Casein Kinase 1 dynamics that govern circadian period.
Ricci C, Philpott J, Torgrimson M, Freeberg A, Narasimamurthy R, de Barros E bioRxiv. 2025; .
PMID: 39896482 PMC: 11785140. DOI: 10.1101/2025.01.17.633651.
Zebrafish as model system for the biological characterization of CK1 inhibitors.
Meier L, Gahr B, Roth A, Gihring A, Kirschner S, Woitaske-Proske C Front Pharmacol. 2023; 14:1245246.
PMID: 37753113 PMC: 10518421. DOI: 10.3389/fphar.2023.1245246.
PERIOD phosphorylation leads to feedback inhibition of CK1 activity to control circadian period.
Philpott J, Freeberg A, Park J, Lee K, Ricci C, Hunt S Mol Cell. 2023; 83(10):1677-1692.e8.
PMID: 37207626 PMC: 11684667. DOI: 10.1016/j.molcel.2023.04.019.
Target binding triggers hierarchical phosphorylation of human Argonaute-2 to promote target release.
Bibel B, Elkayam E, Silletti S, Komives E, Joshua-Tor L Elife. 2022; 11.
PMID: 35638597 PMC: 9154749. DOI: 10.7554/eLife.76908.
Kinase domain autophosphorylation rewires the activity and substrate specificity of CK1 enzymes.
Cullati S, Chaikuad A, Chen J, Gebel J, Tesmer L, Zhubi R Mol Cell. 2022; 82(11):2006-2020.e8.
PMID: 35353987 PMC: 9177650. DOI: 10.1016/j.molcel.2022.03.005.